Case Report | Open Access
Ayako Ura, Kanako Ogura, Asumi Sakaguchi, Hiroko Onagi, Daiki Ogishima, Yayoi Sugimori, Kensuke Hamamura, Masaharu Fukunaga, Toshiharu Matsumoto, "Coexistence of Cervical Leiomyosarcoma and Gastric-Type Adenocarcinoma In Situ with Extensive Extension to the Endometrium and Fallopian Tube", Case Reports in Pathology, vol. 2018, Article ID 5848629, 6 pages, 2018. https://doi.org/10.1155/2018/5848629
Coexistence of Cervical Leiomyosarcoma and Gastric-Type Adenocarcinoma In Situ with Extensive Extension to the Endometrium and Fallopian Tube
Cervical leiomyosarcoma is known to be rare from the previous reviews of a large number of malignant cervical tumors. The patient was a 66-year-old woman with irregular vaginal bleeding. She underwent modified radical hysterectomy and bilateral salpingooophorectomy. Histopathologically, we diagnosed the coexistence of uterine cervical leiomyosarcoma and cervical gastric-type adenocarcinoma in situ with endometrial lesions that had continuous and skip patterns and fallopian tubal lesions with a partial lesion. To the best of our knowledge, cases of synchronous leiomyosarcoma and cancers have not often been reported; only two cases of synchronous cervical leiomyosarcoma and cervical squamous cell carcinoma have been published. This case is the first presentation of coincidental primary cervical leiomyosarcoma and cervical gastric-type adenocarcinoma in situ. Additionally, we considered cervical gastric-type adenocarcinoma in situ with continuous lesions on the endometrium and skip lesions on the left fallopian tube.
Cervical sarcoma is a rare neoplasm; Wright et al. reported that among 1583 patients with cervical malignancies, eight cervical sarcomas were identified, and only one patient had leiomyosarcoma . Thereafter, Khosla et al. reported similar findings in 1804 patients with cervical malignancies; eight cervical sarcomas were identified, and three patients had leiomyosarcoma . Cervical leiomyosarcoma is extremely rare; only six cases have been reported, only two of which were synchronous endocervical leiomyosarcoma and endocervical squamous cell carcinoma [3–7].
To the best of our knowledge, synchronous occurrence of leiomyosarcoma and adenocarcinoma in the cervix has not been reported.
Here, we reported the first case with synchronous occurrence of leiomyosarcoma and adenocarcinoma in situ in the cervix. Moreover, in our case, synchronous occurrence of intraepithelial carcinoma was observed in the endometrium and fallopian tube.
2. Case Presentation
2.1. Clinical Course
The patient, a 66-year-old gravida one-para one woman, was referred to Juntendo University Nerima Hospital with irregular vaginal bleeding and watery vaginal discharge. The hydrometra, with a diameter of approximately cm by ultrasound examination, was found. Diffusion weighted magnetic resonance imaging revealed an abnormal mass with a diameter of approximately 2 cm on the left sidewall of the uterine corpus without any lymph node enlargement (Figure 1(a)). Fluorodeoxyglucose-positron emission tomography showed abnormal uptake in the mass with a maximal standardized uptake value (SUV, max) of 7.79 (Figure 1(b)). Serum tumor markers, including CEA, CA19-9, and CA125, were within normal limits.
Histological examination of the endometrial biopsy established the diagnosis of leiomyosarcoma and atypical endometrial epithelial lesion. A modified radical hysterectomy and bilateral salpingooophorectomy were performed. After the surgery, the patient was not treated with additional treatments. She had no recurrence within seven months after the operation.
2.2. Pathological Finding of Resected Tissues
In the uterus, a 1.5 cm sized brownish mass was found in the cervix near the corpus; it was located in the stroma with an irregular border. The lumen of the corpus was expanded, and the mucosa was diffusely irregular. There was no nodule or tumorous mass in the corpus. There were no abnormal findings in the bilateral adnexa (Figure 2).
Histologically, the cervical mass was highly cellular and consisted of densely packed spindle-shaped to oval-shaped cells with high-grade atypia with a fascicular patterned arrangement and occasional lymphocytic infiltration. It infiltrated beneath the mucosa (Figures 3(a) and 3(c)). High mitotic activity and focal necrosis with hemorrhage were also noted in the mass (Figure 3(b)). Immunohistochemically, the spindle and oval cells were positive for vimentin, SMA, and H-caldesmon (Figure 3(d)) and were negative for epithelial markers and ALK (Table 1). From the histological findings and immunohistochemical results, the mass was finally diagnosed as leiomyosarcoma.
Furthermore, irregularity of the epithelium was noted in the cervical mucosa and endometrium. Histologically, atypical epithelial and glandular cells with nuclear irregularity, variable sizes, mitosis, and apoptosis and without stromal invasion were noted in the cervix. Part of the glands had abundant pale eosinophilic cytoplasm, and part of the glands had intestinal differentiation with goblet cells (Figures 4(a) and 4(b)). These findings led to the diagnosis of adenocarcinoma in situ (AIS). The carcinoma cells consisted mostly of gastric-type cells and partly of intestinal type cells from the histological features and immunohistochemical findings (Figures 5(a) and 5(b), Table 2). Similar intraepithelial carcinoma cells were present in the endometrium as continuous and skip patterns and in the left fallopian tube as a partial lesion. Stromal invasion was noted in all lesions (Figures 4(c) and 4(d)). In the cervix and endometrium, mucinous metaplasia and stratified mucinous-producing intraepithelial lesion (SMILE) was admixed with intraepithelial carcinoma lesions (Figures 4(e) and 4(f)). In the left tube, atypical epithelial cells that had less atypia compared with carcinoma were admixed.
ND, not done.
Synchronous gynecological cancers are rare [8–10]. From the detailed literature reviews of uterine sarcoma with synchronous occurrence of carcinoma as indicated in Table 3, the present case is the first case with synchronous occurrence of leiomyosarcoma and adenocarcinoma in situ in the cervix [3–7]. Concerning the diagnosis of leiomyosarcoma, three differential diagnoses were considered: leiomyosarcoma, inflammatory myofibroblastic tumor (because these lesions had lymphocytic infiltration), and carcinosarcoma (because focally spindle atypical cells and epithelial lesions were very close). We denied the possibility of an inflamed myofibroblastic tumor because the lesion had high-grade cellular atypia and high mitotic activity and was ALK negative, and we denied the possibility of carcinosarcoma as a result of the absence of a carcinomatous element within the sarcoma lesion. Leiomyosarcoma was finally diagnosed from histological appearances and positive H-caldesmon results, although desmin was negative.
TC, tunnel cluster; TZ, transformation zone; LEGH, lobular endocervical glandular hyperplasia; SGM, simple gastric metaplasia; SMILE, stratified mucin-producing intraepithelial lesion.
However, in the present case, gastric-type AIS (gAIS) was noted in the cervix, endometrium, and tube. Most endocervical glandular malignancies and their precursors are associated with high-risk human papilloma virus (HPV); however, some endocervical glandular gastric-type lesions were not associated with HPV. In the 2014 World Health Organization (WHO) classification, malignancies and their precursors of gastric-type cervical lesions, including lobular endocervical glandular hyperplasia (LEGH), minimal deviation adenocarcinoma (MDA), and gastric-type adenocarcinoma (GAS), were listed as endocervical lesions with a gastric phenotype [11, 12]. In particular, GAS is defined as a neoplasm composed of cells with abundant pale or eosinophilic cytoplasm and distinct cell borders, and it is considered that a precursor of GAS is gAIS. gAIS is defined as preexisting endocervical glands that are replaced by atypical columnar cells with abundant pale to eosinophilic cytoplasm and distinct cell borders without lobular architecture. Immunohistochemically, the glandular cells are focally positive for MUC6 and/or HIK1083 and sometimes diffusely positive for p53. ER and PgR are negative, and p16 is usually negative . The classification of gastric-type cervical lesions has been established; the cases previously diagnosed as cervical type mucinous adenocarcinoma may be included in GAS and gAIS; there is a high probability that case reports will increase in the future .
Our case was diagnosed as endocervical gAIS from histological features and immunohistochemical results. In addition, synchronous occurrence of intraepithelial carcinoma was also noted in the endometrium with continuous and skip patterns and in the tube with partial lesions. Talia et al. reported nine cases in total; of these, three cases had intraepithelial spreading to endometrium . We compared our case with these three cases of gAIS with intraepithelial spreading to the endometrium (there was extension to the lower segment, and, in two cases, there was involvement of the endometrium in the lower corpus with continuous lesions) (Table 4). Our case not only had continuous lesions to the endometrium but also had tubal skip lesions that were confirmed by continuous sectioning (Figure 6). However, because the tubal skip lesions were similar to other lesions, we suggested that these lesions were most likely not multifocal lesions but a series of lesions.
This is the first report of coincidental primary cervical leiomyosarcoma and cervical gastric-type AIS with intraepithelial spreading to the corpus and fallopian tube.
Conflicts of Interest
The authors declare that there are no conflicts of interest.
- J. D. Wright, K. Rosenblum, P. C. Huettner et al., “Cervical sarcomas: An analysis of incidence and outcome,” Gynecologic Oncology, vol. 99, no. 2, pp. 348–351, 2005.
- D. Khosla, R. Gupta, R. Srinivasan, F. D. Patel, and A. Rajwanshi, “Sarcomas of uterine cervix: Clinicopathological features, treatment, and outcome,” International Journal of Gynecological Cancer, vol. 22, no. 6, pp. 1026–1030, 2012.
- B. Wiston, J. Gerale, and C. Sheldon, “Coincidental primary srcoma and carcinoma of the cervix, report of two cases,” Obstetrics and Gynecology, vol. 33, no. 1, 1969.
- K. Dudzik, A. Krzysteczko, L. Kolny, A. Bąk, E. Stawicka-Ociepka, and K. Nowosielski, “Synchronous uterine adenocarcinoma and leiomyosarcoma - A case study,” Przegląd Menopauzalny, vol. 16, no. 1, pp. 23–25, 2017.
- K. Katie, C. Eric, and A. Edwin, “Synchronous uterine adenocarcinoma and leiomyosarcima: a rare case report causing a clinical conundrum,” International Journal of Surgery Case Reports, vol. 22, pp. 32–34, 2016.
- A. Isin Dogan Ekici, T. Kucukali, M. Coskun Salman, and A. Ayhan, “Triple simultaneous primary gynecological malignancies in a 56-year-old patient,” International Journal of Gynecological Cancer, vol. 16, no. 5, pp. 1947–1950, 2006.
- I. Sheyn, J. L. Mira, R. Blanco et al., “Concomitant well-differentiated adenocarcinoma and leiomyosarcoma of the uterus,” Archives of Pathology & Laboratory Medicine, vol. 124, pp. 1539–1541, 2000.
- B. Saatli, N. Yildirim, A. Ozay, M. Koyuncuoglu, B. Demirkan, and U. Saygılı, “Synchronous tumors of the female genital tract: a 20-year experience in a single center,” Polish Gynaecology, vol. 85, no. 6, pp. 441–445, 2014.
- S. Y. Tong, Y. S. Lee, J. S. Park et al., “Clinical analysis of synchronous primary neoplasm of the female reproductive tract,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 136, pp. 78–82, 2008.
- C. Amalinei, R. Balan, E. Crauciuc, and O. Toma, “Synchronous, metachronous and metastatic tumoes of the upper female genital tract,” Annals of the "Alexandru Ioan Cuza" University, Sect. II a, Genetics and molecular biology, vol. 9, pp. 1–22, 2008.
- G. D. Zielinski, P. J. F. Snijders, L. Rozendaal et al., “The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix,” The Journal of Pathology, vol. 201, no. 4, pp. 535–543, 2003.
- R. J. Kurman, M. L. Carcangiu, C. S. Herrington, and R. H. Young, WHO classification of tumors of female reproductive organs, IARC, Lyon, France, 2014.
- Y. Mikami and W. G. McCluggage, “Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions,” Advances in Anatomic Pathology, vol. 20, no. 4, pp. 227–237, 2013.
- A. Kojima, Y. Mikami, T. Sudo et al., “Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix,” The American Journal of Surgical Pathology, vol. 31, no. 5, pp. 664–672, 2007.
- K. L. Talia, C. J. R. Stewart, B. E. Howitt, M. R. Nucci, and W. G. McCluggage, “HPV-negative Gastric Type Adenocarcinoma in Situ of the Cervix,” The American Journal of Surgical Pathology, vol. 41, no. 8, pp. 1023–1033, 2017.
Copyright © 2018 Ayako Ura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.